Search

The reaction of the phosphorus trihydrazide, (S)P[N(Me)-NH2]3(1) with quinoline-2-carboxaldehyde (C9H6N-2-CHO) in a 1 : 3 ratio afforded a trishydrazone, (S)P[N(Me)-NCH-2-C9H6N]3(2). Crystals of 2were grown in three different solvent media affording an unsolvated (2, monoclinic, P21/n) and two solvated (2·3H2O, trigonal, R3 and 2·2CH3OH, triclinic, P1) crystal forms. Each of these, while possessing an essentially similar molecular structure, adopt different crystal packing giving rise to supramolecular structures mediated by a variety of weak interactions: O–H–N, O–H–O, C–H–N, C–H–O, C–H–S, C–H–π, π–π, N–π and S–π. The reaction of 2with Ag(ClO4)2·6H2O in methanol afforded a dinuclear cationic cage [Ag{(S)P[N(Me)-NCH-2-C9H6N]3}·ClO4]2(3). The molecular structure of 3reveals a dimeric structure consisting of two AgIions that are held together by two ligands. Only two arms of the tris hydrazone ligand are involved in coordination while an unprecedented PS→AgIcoordination is seen. This results in the formation of an Ag2S2dimer that is encapsulated by two trishydrazone ligands. Both compounds 2and 3are photoluminescent. [ABSTRACT FROM AUTHOR]

Phosphonate ligands, [RPO3]2-, are extremely versatile in the assembly of multi-tin and multi-copper architectures. We have used organostannoxane cores for supporting multi-ferrocene and multi-porphyrin peripheries. The copper-metalated multi-porphyrin compound is an excellent reagent for facile cleavage of DNA, even in the absence of a co-oxidant. Reaction of t-BuPO3H2 with Cu(ClO4)2. 6H2O in the presence of 2-pyridylpyrazole (2-Pypz) leads to the synthesis of a decanuclear copper (II) assembly. [ABSTRACT FROM AUTHOR]

A multicomponent synthetic strategy involving copper(II) ions, tert-butylphosphonic acid (t-BuPO3H2) and 3-substituted pyrazole ligands has been adopted for the synthesis of soluble molecular copper(II) phosphonates. The use of six different 3-substituted pyrazoles, 3-R-PzH [R = H, Me, CF3, Ph, 2-pyridyl (2-Py), and 2-methoxyphenyl (2-MeO-C6H4)] as ancillary ligands afforded nine different decanuclear cages, [Cu5(μ3-OH)2(O3P-t-Bu)3(3-R-Pz)2(X)2]2·(Y) where R = H, X = t-BuPO3H, and Y = (Et3NH+)4(solvent) (1); R = Me, X = 3-MePzH, and Y = solvent (2); R = Me, X = t-BuPO3H, and Y = (Et3NH+)4(solvent) (3); R = CF3, X = t-BuPO3H, and Y = (Et3NH+)4(solvent) (4); R = Ph, X = 3-PhPzH, and Y = solvent (5); R = 2-Py, X = 0.5 MeOH, and Y = solvent (6); R = 2-Py, X = none, and Y = solvent (7); R = 2-Py, X = H2O, and Y = (Et3NH+·PF6-)2(solvent) (8); R = 2-MeO-C6H4, X = MeOH or 0.5:0.5 MeOH/H2O, and Y = solvent (9). Compounds 1-6, 8, and 9 were isolated using a direct synthetic method which involves the reaction of copper(II) salts and the ligands, while 7 was obtained from an indirect route involving the reaction of preformed copper-pyridylpyrazolate precursor complexes and t-BuPO3H2. The decametallic compounds 1-9 possess a butterfly shaped core. The core of the cages 1, 3, and 4 are tetraanionic and contain more phosphonates than pyrazole ligands, while the other cages are neutral and contain more pyrazoles than phosphonate ligands. Compounds 1-6 have been studied by electrospray ionization-high-resolution mass spectrometry (ESI-HRMS). The decanuclear cage 6 was shown to be a good plasmid modifier. [ABSTRACT FROM AUTHOR]